The acetylated IGF2BP3‐PCK2‐SAM‐m6A axis sustained higher expression of PCK2 and NRF2, reinforced the antioxidant defense, and promoted lenvatinib resistance in HCC. Here, PCK2 is linked to hepatocellular carcinoma.